Summary of GN Store Nord Conference Call Company and Industry - **Company**: GN Store Nord (OTCPK:GNND.Y) - **Industry**: Audiology and Technology Innovation Key Points and Arguments Transaction Overview - GN Store Nord announced the sale of its hearing business to Amplifon for a total consideration of **DKK 17 billion** [2][7] - The transaction aims to create a global leader in audiology and allows GN to focus on technology innovation in enterprise, gaming, and defense markets [2][4] Financial Details - The hearing business generated **DKK 7.2 billion** in revenue in 2025 with a healthy margin [6] - Amplifon, the world's largest hearing aid retailer, reported nearly **DKK 18 billion** in revenue and an adjusted EBITDA of **DKK 4 billion** in 2025 [6] - GN will receive **DKK 2.6 billion** in cash and **56 million shares** in Amplifon, valued at approximately **DKK 4.4 billion** [8] Strategic Rationale - The sale is seen as a way to unlock a strong balance sheet, enabling continued investments and shareholder returns [2][3] - The transaction is expected to create significant future value for both GN and Amplifon, enhancing their positions in the audiology market [4][6] Market Position and Growth Opportunities - GN has established strong positions in audio and video peripherals, with a focus on enterprise headsets and gaming devices [10][15] - The company aims for organic revenue growth of **2%-8%** in 2026, with specific growth targets of **0%-6%** in enterprise and **7%-13%** in gaming [18] Capital Allocation and Financial Guidance - Initial proceeds from the transaction will exceed GN's current net interest-bearing debt of **DKK 8.6 billion** [17] - Plans include reducing debt, investing in growth opportunities, and resuming shareholder distributions [17] - Long-term financial targets have been suspended, but ambitions for profitable growth remain unchanged [19] Operational Considerations - The hearing business will be classified as discontinued operations, affecting future revenue reporting [18][76] - GN is committed to managing potential disruptions during the transition and ensuring continued innovation in its remaining business segments [45][46] Shareholder Engagement and Future Strategy - A Capital Markets Day is planned post-transaction to discuss future strategy, financial targets, and capital allocation policies [19] - GN will retain a **16% stake** in Amplifon, with plans to evaluate this shareholding responsibly over time [39][65] Regulatory and Market Risks - The transaction is subject to regulatory approvals, with GN confident in its ability to navigate these processes [45] - Concerns about antitrust reviews were acknowledged, but the board believes the deal's structure minimizes risks [45][46] Additional Important Points - The hearing business has been growing faster than the market for four consecutive years, indicating strong operational performance [5] - GN's focus on technology leadership and innovation is expected to drive future growth in its remaining business segments [10][14] This summary encapsulates the key discussions and strategic insights from the conference call regarding GN Store Nord's transaction with Amplifon and its implications for the company's future direction and market positioning.

Core Insights - GN faced a challenging year in 2025 due to external factors but managed to execute well in areas under its control, preparing for future profitable growth through innovation and operational initiatives [2][21] Financial Performance Overview - Group revenue for 2025 was DKK 16,782 million, reflecting a decline of 7% from DKK 17,985 million in 2024, with reported organic revenue growth of -4% [5][23] - Group EBITA decreased to DKK 1,908 million, down from DKK 2,153 million in 2024, resulting in an EBITA margin of 11.4% [6][24] - Free cash flow excluding M&A was DKK 1,112 million, contributing to a reduction in net interest-bearing debt by DKK 0.8 billion to DKK 8.9 billion, maintaining leverage at 3.8x [6][10] Division Performance Hearing Division - The Hearing division achieved 5% organic growth in 2025, building on previous years' growth of 10% in 2024 and 13% in 2023, driven by the ReSound Vivia platform [3][8] - Revenue for the Hearing division reached DKK 7,214 million, up from DKK 7,104 million in 2024 [3][23] Enterprise Division - The Enterprise division experienced a decline in organic growth of -6% in 2025, with revenue falling to DKK 6,899 million from DKK 7,474 million in 2024 [4][23] - The division maintained its market-leading position despite challenges from uncertain trade policies [4][21] Gaming Division - The Gaming division reported organic revenue growth of -2% in 2025, with total revenue at DKK 2,669 million [5][23] - The division faced a difficult market environment but managed to gain market share [5][21] Future Outlook - For 2026, GN expects organic revenue growth of 3% to 7% for the Hearing division, 0% to 6% for the Enterprise division, and 7% to 13% for the Gaming division [11][17] - The EBITA margin is projected to improve, supported by gross margin expansion and operational leverage [18][19]

Core Insights - The company has confirmed its financial guidance for 2025, expecting organic revenue growth to range from -2% to +2%, an EBITA margin of 11% to 13%, and free cash flow of approximately DKK 800 million [2][7]. Hearing Division - The hearing aid market is projected to grow at 4-6% in volume, with GN expecting organic revenue growth of 5% to 9% in 2025, although it may be at the lower end due to a slower market growth assumption [3]. - The Hearing division achieved 7% organic revenue growth in the recent quarter, driven by strong sales of ReSound Vivia, resulting in a divisional profit margin of 34% [7]. Enterprise Division - The Enterprise division is facing challenges due to uncertainties in the trade environment, with expected organic revenue growth of -8% to 0% for 2025 [4]. - Despite these challenges, the division experienced positive sell-out growth outside of Europe, but organic revenue growth ended at -4% due to market uncertainties in Europe [7]. Gaming Division - The Gaming division is also affected by changes in the trade environment and weak consumer sentiment, with expected organic revenue growth of -6% to +2% for 2025 [5]. - The division delivered 3% organic growth in the recent quarter, achieving a profit margin of 9% despite tariff costs [7]. EBITA Margin and Financial Performance - The company has implemented significant actions to protect profitability, including diversifying the manufacturing footprint and adjusting prices in the U.S. [6]. - The reported EBITA for the quarter was DKK 435 million, resulting in an EBITA margin of 11%, reflecting revenue developments and strong cost control [7]. - Free cash flow, excluding M&A, was DKK 410 million, with net interest-bearing debt at DKK 9.4 billion, indicating a reported leverage of 4.0x [7][8].

Core Insights - The company has confirmed its financial guidance for 2025, narrowing organic revenue growth expectations to a range of -2% to +2% [8][12] - The Hearing division is expected to contribute organic revenue growth of 5% to 9%, but due to lower market growth assumptions, it is now anticipated to grow at the lower end of that range [5][4] - The Enterprise division is facing challenges due to market uncertainty, with expected organic revenue growth of -8% to 0% [6] - The Gaming division is also impacted by trade environment changes, with organic revenue growth now expected in the upper half of the range of -6% to +2% [7] Financial Performance - Group reported EBITA increased by 46% to DKK 546 million, with an EBITA margin of 13% [8] - Free cash flow excluding M&A was DKK 353 million, reflecting a positive earnings profile and working capital impact [8] - The Hearing division achieved 8% organic revenue growth, while the Enterprise division saw a decline of -7% [8][10] Market Conditions - The hearing aid market is projected to grow at 4-6% in volumes, driven by favorable demographic trends, but is expected to grow slower than its structural trend in 2025 [4] - The company is actively diversifying its manufacturing footprint and implementing price adjustments to mitigate impacts from the changing trade environment [6][9] - The overall impact of tariffs is expected to reduce the group EBITA margin by approximately -1% in 2025 [10]

Core Insights - GN Store Nord has adjusted its financial guidance for 2025, now expecting organic revenue growth of -3% to +3%, an EBITA margin of 11% to 13%, and free cash flow excluding M&A to remain around DKK 800 million [2][6]. Financial Guidance for 2025 - The company anticipates organic revenue growth excluding wind to be down from a prior estimate of 3% to 7% to a new range of -3% to +3% [2]. - EBITA margin guidance has been revised down from 12% to 14% to a new range of 11% to 13% [2]. - Free cash flow excluding M&A is confirmed to be approximately DKK 800 million, unchanged from previous guidance [2]. Revenue Assumptions by Division Hearing Division - GN expects the hearing aid market to grow at historical rates, projecting a market volume growth of 4-6% and a market value growth of 3-5% in 2025 [3]. - The division aims for organic revenue growth of 5% to 9%, supported by the launch of ReSound Vivia and ReSound Savi [3]. Enterprise Division - The current market environment has led to uncertainty, causing companies to postpone IT projects, which negatively impacts the addressable market [4]. - The division anticipates organic revenue growth of -8% to 0% due to these challenges and prioritization of product variants shipped to the U.S. [4]. Gaming Division - The gaming gear market is expected to be negatively impacted by a decline in consumer sentiment in the U.S. and global economic uncertainty [5]. - The division projects organic revenue growth of -6% to +2%, excluding the impact from the wind-down of certain product lines [5]. Q1 2025 Financial Performance - GN reported a group revenue of DKK 3,986 million for Q1 2025, reflecting a 7% decline compared to Q1 2024 [6]. - The Hearing division experienced a -1% organic revenue growth, while the Enterprise division faced a -9% decline [6]. - The Gaming division reported an 11% organic revenue growth, excluding the impact from the wind-down of certain product lines [6]. - Group EBITA was DKK 300 million, with an EBITA margin of 8%, indicating a significant decline from previous periods [6]. - Free cash flow excluding M&A was reported at DKK -395 million, influenced by seasonality and higher interest payments [6]. Management Commentary - The CEO expressed confidence in the underlying strength of the business despite short-term challenges and emphasized the successful launch of ReSound Vivia [6][8]. - The company is taking significant actions to mitigate the impact of tariffs, including diversifying its manufacturing footprint and implementing price increases in the U.S. [6][9].

Core Viewpoint - GN is taking proactive measures to mitigate the negative impacts of increased tariffs on its EBITA margin and mid-term earnings growth, aiming to counteract the uncertainty in the market environment [1][2][3]. Financial Guidance for 2025 - GN's updated financial guidance for 2025 indicates an organic revenue growth expectation of -3% to +3%, with an EBITA margin projected to be 11% to 13%, and confirmed free cash flow of approximately 800 million DKK [4]. Hearing Division - The hearing aid market is expected to grow at a rate of 4-6% in volume, with a slight decline in average selling price (ASP) of -1%, leading to an overall market value growth of 3-5%. GN anticipates organic revenue growth of 5% to 9% in this division [6]. Enterprise Division - The Enterprise division is facing a negative impact on revenue growth, projected at -8% to 0%, due to postponed IT projects and prioritization of product variants shipped to the U.S. until supply chain diversification is completed [7]. Gaming Division - The Gaming division expects organic revenue growth of -6% to +2%, influenced by a decline in consumer sentiment and prioritization of product variants for U.S. customers. The company is accelerating its manufacturing diversification to reduce reliance on China by the end of 2025 [8][9].